ES2174445T3 - Nueva clase de agentes transfectantes cationicos de los acidos nucleicos. - Google Patents

Nueva clase de agentes transfectantes cationicos de los acidos nucleicos.

Info

Publication number
ES2174445T3
ES2174445T3 ES98928418T ES98928418T ES2174445T3 ES 2174445 T3 ES2174445 T3 ES 2174445T3 ES 98928418 T ES98928418 T ES 98928418T ES 98928418 T ES98928418 T ES 98928418T ES 2174445 T3 ES2174445 T3 ES 2174445T3
Authority
ES
Spain
Prior art keywords
cluster
inclusive
hydrogen atom
nucleic acids
new class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98928418T
Other languages
English (en)
Inventor
Michel Bessodes
Daniel Scherman
Jean Herscovici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2174445T3 publication Critical patent/ES2174445T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Agente transfectante que comprende al menos una región hidrófila catiónica, acoplada con una región lipófila, caracterizada porque la citada región hidrófila catiónica tiene como fórmula general: en la que - y es un número entero igual a 0 o 1, siendo independientes entre sí los diferentes y, - X representa un átomo de oxígeno, de nitrógeno, de azufre o de selenio, - los agrupamientos Z representan, independientemente entre sí, un átomo de hidrógeno, un agrupamiento OR, en que R representa un átomo de hidrógeno, un agrupamiento metilo, o un agrupamiento (CH2)n- NR1R2, en el que n es un número entero elegido de 1 a 6 inclusive y R1 y R2 representan, independien- temente entre sí, un átomo de hidrógeno o un agrupamiento (CH2)q-NH2, pudiendo variar q de 1 a 6 inclusive, siendo independientes entre sí, los diferentes q, un agrupamiento (CH2)m-NR1R2, en el que m es un número entero elegido de 0 a 6 inclusive y R1 y R2 se definen como anteriormente, o bien un agrupamiento "espaciador" que permitala unión de la región hidrófila catiónica con la región lipófila, entendiéndose que al menos uno de los substituyentes Z es un agrupamiento "espaciador" y que al menos de los substituyentes Z portan un agrupamiento amino.
ES98928418T 1997-06-06 1998-06-03 Nueva clase de agentes transfectantes cationicos de los acidos nucleicos. Expired - Lifetime ES2174445T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707014A FR2764304B1 (fr) 1997-06-06 1997-06-06 Nouvelle classe d'agents transfectants cationiques des acides nucleiques

Publications (1)

Publication Number Publication Date
ES2174445T3 true ES2174445T3 (es) 2002-11-01

Family

ID=9507684

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98928418T Expired - Lifetime ES2174445T3 (es) 1997-06-06 1998-06-03 Nueva clase de agentes transfectantes cationicos de los acidos nucleicos.

Country Status (18)

Country Link
EP (1) EP0986568B1 (es)
JP (1) JP2002504815A (es)
KR (1) KR20010013312A (es)
CN (1) CN1259134A (es)
AT (1) ATE214708T1 (es)
AU (1) AU737579B2 (es)
BR (1) BR9809953A (es)
CA (1) CA2292837A1 (es)
DE (1) DE69804302T2 (es)
DK (1) DK0986568T3 (es)
ES (1) ES2174445T3 (es)
FR (1) FR2764304B1 (es)
HU (1) HUP0004577A3 (es)
NO (1) NO314147B1 (es)
PL (1) PL337177A1 (es)
PT (1) PT986568E (es)
WO (1) WO1998055490A1 (es)
ZA (1) ZA984845B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9383998A (en) * 1997-09-08 1999-03-29 Valentis, Inc. Hydrophobic glycosylamine derivatives, compositions, and methods for use
DE19942864A1 (de) * 1999-09-08 2001-03-15 Knoell Hans Forschung Ev Neue O-(Aminoalkyl)-Derivate von Monosacchariden, Verfahren zu ihrer Herstellung und ihre Verwendung als antibakterielle Mittel
DE60232258D1 (de) * 2001-08-29 2009-06-18 Aventis Pharma Sa Lipid-aminoglykosid konjugate zur transfektion
FR2829136B1 (fr) * 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
PL2027137T3 (pl) 2005-06-08 2015-08-31 Amicus Therapeutics Inc Oczyszczanie imino- i aminocukrów
WO2008081686A1 (ja) * 2006-12-28 2008-07-10 Konica Minolta Holdings, Inc. コレステロール誘導体、リポソーム、リポソームの形成方法およびx線用造影剤
CN108779074A (zh) * 2016-03-01 2018-11-09 分子传递有限公司 植物病毒移动蛋白和其使用方法
JP7384832B2 (ja) * 2018-05-16 2023-11-21 トランスレイト バイオ, インコーポレイテッド リボースカチオン性脂質
JP2021534196A (ja) 2018-08-23 2021-12-09 シージェン インコーポレイテッド 抗tigit抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774417B2 (ja) * 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
DE4329093A1 (de) * 1993-08-30 1995-03-02 Bayer Ag Substituierte Aminoalkylglycoside
WO1996024334A1 (en) * 1995-02-10 1996-08-15 Nexstar Pharmaceuticals, Inc. Lipid constructs for cytoplasmic delivery of agents

Also Published As

Publication number Publication date
HUP0004577A1 (hu) 2001-04-28
AU8025098A (en) 1998-12-21
CA2292837A1 (fr) 1998-12-10
HUP0004577A3 (en) 2003-03-28
KR20010013312A (ko) 2001-02-26
CN1259134A (zh) 2000-07-05
PL337177A1 (en) 2000-08-14
EP0986568A1 (fr) 2000-03-22
AU737579B2 (en) 2001-08-23
DE69804302T2 (de) 2002-10-17
FR2764304A1 (fr) 1998-12-11
NO995858D0 (no) 1999-11-30
ZA984845B (en) 1998-12-29
FR2764304B1 (fr) 1999-07-16
DK0986568T3 (da) 2002-06-10
DE69804302D1 (de) 2002-04-25
WO1998055490A1 (fr) 1998-12-10
EP0986568B1 (fr) 2002-03-20
PT986568E (pt) 2002-08-30
JP2002504815A (ja) 2002-02-12
BR9809953A (pt) 2000-08-01
NO314147B1 (no) 2003-02-03
NO995858L (no) 1999-11-30
ATE214708T1 (de) 2002-04-15

Similar Documents

Publication Publication Date Title
AR013230A1 (es) Citolisis dirigida de celulas blanco, agentes y composiciones que la provocan y compuestos que se pueden emplear para producir dichos agentes
MX9702030A (es) Derivado de imidazol.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
ES2033774T3 (es) Derivados antiviricos fosfonometoxialquilenicos de purina y pirimidina.
ES2191699T3 (es) Poliaminas ciclicas.
ES2151185T3 (es) Lipopoliaminas como agentes de transfeccion y sus aplicaciones farmaceuticas.
ES2196305T3 (es) Composiciones que contienen moleculas inmunogenas y factor de estimulacion de colonias de granulocitos magrofagos como adyuvante.
ES2175631T3 (es) Dispositivo para la aplicacion de mechas de un producto capilar.
DK198291A (da) Azidosulfat
ATE133181T1 (de) Dehydrodidemnin b
DE50210313D1 (de) Amphotere sterole und deren verwendung
AU6679386A (en) 5-acylamido-1-aryl-pyrazoles
ES2174445T3 (es) Nueva clase de agentes transfectantes cationicos de los acidos nucleicos.
ES2106783T3 (es) 1-benzopiran-4-onas y 2-amino-1,3-benzoxacin-4-onas antiarterosclerosis y antitromboticas.
DE3781546D1 (de) Stabile loesungsmitteladdukte von z-1-(p-beta-dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-en.
ES2122275T3 (es) Derivados amidicos de la vitamina d.
AR005999A1 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos
FR2718963B1 (fr) Nouvelle composition pharmaceutique à base de taxoïdes.
CY1105763T1 (el) Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους
PA8461601A1 (es) Isoquinolinas
EA199901113A1 (ru) Карбоксамиды в качестве агонистов 5-ht1f
ATE263659T1 (de) Manipulator
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
DK1147212T3 (da) T-hjælpecelle-epitoper

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 986568

Country of ref document: ES